Search research articles
Contact Us
Filters
Showing results (111-120 of 191) with videos related to
Page
of 20
Sort By:
Molecular Pharmaceutics
|
May 17, 2014
Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model
Adam J Shuhendler, Preethy Prasad, Rui Xue Zhang, et al.
The Canadian Journal of Cardiology
|
October 3, 2017
N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure
Jason G E Zelt, Peter P Liu, Fernanda Erthal, et al.
Circulation
|
September 14, 2013
Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production
Alan Valaperti, Mototsugu Nishii, Youan Liu, et al.
CJC Open
|
October 18, 2022
Epidemiology of COVID-19 and Its Cardiac and Neurologic Complications Among Chinese and South Asians in Ontario: Waves 1, 2, and 3
Joseph Y Chu, Gordon W Moe, Manav V Vyas, et al.
Circulation Research
|
July 23, 2005
Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice
Zamaneh Kassiri, Gavin Y Oudit, Otto Sanchez, et al.
Diabetologia
|
November 8, 2025
Cardiovascular effectiveness and safety of SGLT2 inhibitors vs DPP4 inhibitors by dementia status: a cohort study of older adults with diabetes
Che-Yuan Wu, Abhinav Sharma, Jodi D Edwards, et al.
Journal of the American Heart Association
|
April 24, 2013
Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways
Mei Sun, Maral Ouzounian, Geoffrey de Couto, et al.
Cardiovascular Research
|
February 19, 2008
Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress
Gavin Y Oudit, Zamaneh Kassiri, Joyce Zhou, et al.
Thrombosis and Haemostasis
|
December 2, 2006
Exercise increases tissue-type plasminogen activator expression in rat cardiomyocytes
Hubert P Walinski, Steve F Gyorffy, Hon S Leong, et al.
Basic Research in Cardiology
|
December 29, 2011
Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction
Jinfeng Xiao, Mark Moon, Ling Yan, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 191) with videos related to
Sort By:
Page
of 20
Molecular Pharmaceutics
|
May 17, 2014
Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model
Adam J Shuhendler, Preethy Prasad, Rui Xue Zhang, et al.
The Canadian Journal of Cardiology
|
October 3, 2017
N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure
Jason G E Zelt, Peter P Liu, Fernanda Erthal, et al.
Circulation
|
September 14, 2013
Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production
Alan Valaperti, Mototsugu Nishii, Youan Liu, et al.
CJC Open
|
October 18, 2022
Epidemiology of COVID-19 and Its Cardiac and Neurologic Complications Among Chinese and South Asians in Ontario: Waves 1, 2, and 3
Joseph Y Chu, Gordon W Moe, Manav V Vyas, et al.
Circulation Research
|
July 23, 2005
Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice
Zamaneh Kassiri, Gavin Y Oudit, Otto Sanchez, et al.
Diabetologia
|
November 8, 2025
Cardiovascular effectiveness and safety of SGLT2 inhibitors vs DPP4 inhibitors by dementia status: a cohort study of older adults with diabetes
Che-Yuan Wu, Abhinav Sharma, Jodi D Edwards, et al.
Journal of the American Heart Association
|
April 24, 2013
Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways
Mei Sun, Maral Ouzounian, Geoffrey de Couto, et al.
Cardiovascular Research
|
February 19, 2008
Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress
Gavin Y Oudit, Zamaneh Kassiri, Joyce Zhou, et al.
Thrombosis and Haemostasis
|
December 2, 2006
Exercise increases tissue-type plasminogen activator expression in rat cardiomyocytes
Hubert P Walinski, Steve F Gyorffy, Hon S Leong, et al.
Basic Research in Cardiology
|
December 29, 2011
Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction
Jinfeng Xiao, Mark Moon, Ling Yan, et al.
Page
of 20